Aesculap Implant Systems
-
Spine
Aesculap Implant Systems Announces the Long-Term Reporting from its Pivotal IDE Trial for the activL® Artificial Disc
CENTER VALLEY, Pa., July 26, 2021 /PRNewswire/ — Aesculap Implant Systems, LLC, a leader in lumbar motion preservation technology, today announced the…
Read More » -
Spine
Five-Year FDA IDE Trial Shows Higher Safety Profile and Greater Effectiveness at Preserving Range of Motion for the activL® Artificial Disc Compared to Previous Generation Lumbar Discs
CENTER VALLEY, Pa., Aug. 15, 2019 /PRNewswire/ — Aesculap Implant Systems, LLC, a leader in lumbar motion preservation technology, today announced the…
Read More » -
Spine
New Study Finds Plasmapore®XP Surface Enhancement Demonstrates Enhanced Osseointegrative Properties
CENTER VALLEY, Pa., Jan. 28, 2019 /PRNewswire/ — Aesculap Implant Systems, LLC today announced the publication of “Porous titanium-coated polyetheretherketone implants exhibit an…
Read More » -
Spine
UnitedHealthcare’s New Positive Medical Policy in Favor of Lumbar Total Disc Replacement Reconfirms the Procedure’s Long-Term Effectiveness for Treatment of Degenerative Disc Disease
CENTER VALLEY, Pa., July 3, 2018 /PRNewswire/ — Aesculap Implant Systems, LLC today announced that UnitedHealthcare® has issued a new, positive medical policy for…
Read More » -
Spine
Aesculap Implant Systems Announces U.S. Military’s TRICARE Now Covers Lumbar Total Disc Replacement
CENTER VALLEY, Pa., June 4, 2018 /PRNewswire/ — Aesculap Implant Systems, LLC announced today that TRICARE now covers the company’s activL® Artificial Disc for…
Read More » -
Spine
Lumbar Artificial Disc Replacement with the activL® Artificial Disc to be More Effective at Delaying the Progression of Adjacent-Level Disease which Spinal Fusion has been Found to Accelerate
CENTER VALLEY, Pa., April 12, 2018 /PRNewswire/ — Aesculap Implant Systems, LLC today announced the publication of “Progression of Adjacent-level Degeneration after Lumbar…
Read More » -
Spine
NASS 2017 Best Paper Sessions Provide Significant Insights into the Long-Term Results of activL® Artificial Disc
CENTER VALLEY, Pa., Nov. 9, 2017 /PRNewswire/ — Aesculap Implant Systems, LLC today announced the significance of the long-term data presented at the…
Read More » -
Hospitals
Aesculap Receives FDA Approval for the activL® Artificial Disc for One-Level Lumbar Use
CENTER VALLEY, PA–(Marketwired – June 15, 2015) – Aesculap Implant Systems, LLC (Aesculap), a privately held medical device company, announced…
Read More »